Evidence map›Paper›PMID 41706361›Full record

ArticleNeurology and therapy2026

Reducing Early-Life Smoke Exposure as a Preventive Strategy for Pediatric Multiple Sclerosis: Results from the PEDIGREE Study.

Silvy Pilotto, Angelo Ghezzi, Stefania Maria Bova, Marzia Fronza, Pietro Annovazzi, Marta Simone, Antonio Gallo, Agnese Suppiej, Roberta Lanzillo, Sarah Rasia and 27 more

Abstract read
In one paragraph

Article in Neurology and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors.

Silvy PilottoDepartment of Neuroscience and Rehabilitation, Sant'Anna University Hospital, University of Ferrara, Via Aldo Moro 8, 44124, Ferrara, Italy. silvy.pilotto@unife.it.ORCID http://orcid.org/0000-0001-7950-0136
Angelo GhezziDepartment of Health Sciences, University of Eastern Piedmont, Novara, Italy.
Stefania Maria BovaChild Neurology Unit, Buzzi Children Hospital, Milan, Italy.
Marzia FronzaDepartment of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Pietro AnnovazziNeuroimmunology Unit-Multiple Sclerosis Center, Hospital of Gallarate, ASST della Valle Olona, Gallarate, Italy.
Marta SimoneChild Neuropsychiatric Unit, Department of Precision and Regenerative Medicine and Jonic Area, University 'Aldo Moro' of Bari, Bari, Italy.
Antonio GalloDepartment of Advanced Medical and Surgical Sciences, and 3T MRI-Center, University of Campania 'Luigi Vanvitelli', Naples, Italy.
Agnese SuppiejPediatric Clinic, University of Ferrara, Ferrara, Italy.
Roberta LanzilloDepartment of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, University of Naples Federico II, Naples, Italy.
Sarah RasiaMultiple Sclerosis Center, ASST-Spedali Civili of Brescia, Montichiari, Brescia, Italy.
Angela BerardinelliChild Neuropsychiatry, IRCCS Mondino Foundation, Pavia, Italy.
Valentina Torri ClericiNeuroimmunology and Neuromuscular Disease Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Lucia MoiolaNeurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Maurizio ViriDepartment of Child Neurology and Psychiatry, AOU Maggiore della Carità Novara, Novara, Italy.
Stefano SotgiuDivision of Child Neuropsychiatry, University Hospital of Sassari, Sassari, Italy.
Simona MalucchiDepartment of Neurology and Multiple Sclerosis Regional Referral Centre, AOU San Luigi Gonzaga, Orbassano, Turin, Italy.
Alessandra ProttiDepartment of Neuroscience, Niguarda Hospital, Milan, Italy.
Carlotta CanavesePediatric Neurology Unit, Regina Margherita Hospital, Turin, Italy.
Giacomo LusSecond Division of Neurology, Department of Clinical and Experimental Medicine, University of Campania Luigi Vanvitelli, Naples, Italy.
Luigi GrimaldiNeurology and Multiple Sclerosis Center, Foundation Institute "G. Giglio", Cefalù, Italy.
Marta Zaffira ContiDepartment of Neurology, Papa Giovanni XXIII Hospital, Bergamo, Italy.
Giovanna BorrielloMS Center, San Pietro Fatebenefratelli Hospital, Rome, Italy.
Giovanna De LucaMS Centre, Neurology Unit, SS. Annunziata University Hospital, Chieti, Italy.
Valentina TomassiniMS Centre, Neurology Unit, SS. Annunziata University Hospital, Chieti, Italy.
Alberto PrioriLaboratory of Precision Medicine of Neurological Diseases, Department of Health Science, "Aldo Ravelli" Center for Neurotechnology and Experimental Brain Therapeutics, University of Milan, Milan, Italy.
Martina TosiDepartment of Health Sciences, University of Eastern Piedmont, Novara, Italy.
Nicola PomellaDepartment of Health Sciences, University of Eastern Piedmont, Novara, Italy.
Andrea CoronaLaboratory of Precision Medicine of Neurological Diseases, Department of Health Science, "Aldo Ravelli" Center for Neurotechnology and Experimental Brain Therapeutics, University of Milan, Milan, Italy.
Alen ZolloLaboratory of Precision Medicine of Neurological Diseases, Department of Health Science, "Aldo Ravelli" Center for Neurotechnology and Experimental Brain Therapeutics, University of Milan, Milan, Italy.
Maria Pia AmatoSection of Neurosciences, Department NEUROFARBA, University of Florence, Florence, Italy.
Eleonora CoccoDepartment of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Maria TrojanoDepartment of Translational Biomedicine and Neurosciences-DiBraiN, University of Bari "Aldo Moro", Bari, Italy.
Filippo Martinelli-BoneschiLaboratory of Precision Medicine of Neurological Diseases, Department of Health Science, "Aldo Ravelli" Center for Neurotechnology and Experimental Brain Therapeutics, University of Milan, Milan, Italy.
Sandra D'AlfonsoDepartment of Health Sciences, University of Eastern Piedmont, Novara, Italy.
Roberto BergamaschiMS Centre, IRCCS Mondino Foundation, Pavia, Italy.
Maura PugliattiDepartment of Neuroscience and Rehabilitation, Sant'Anna University Hospital, University of Ferrara, Via Aldo Moro 8, 44124, Ferrara, Italy.
PEDIGREE Study Group

Funding

Fondazione Italiana Sclerosi Multipla 12/18/F14Fondazione Italiana Sclerosi Multipla Project 2022/R-Multi/013 FISMFondazione Italiana Sclerosi Multipla Research Special Project FISM-2022
6 · The paper itself

Abstract

introductionAssessing the environmental impact on multiple sclerosis (MS) is complex because of long disease latency and potential recall bias, especially for perinatal exposures. This study aimed to investigate the association between parental smoking and the development of pediatric MS (PedMS).

methodsAs part of the Italian multicenter PEDIGREE study, the PEQ-IT questionnaire was used for prospective data collection. We enrolled subjects under 18 years with PedMS (2013 Krupp criteria) and disease duration ≤ 5 years from onset, along with matched controls.

resultsThe study included 114 PedMS cases and 121 controls. Female participants represented 77.2% of cases and 54.4% of controls, with a mean (SD) age of 16.8 (2.7) and 13.5 (4.9) years, respectively. The mean (SD) age at MS onset was 14.2 (2.6) years, and the median EDSS score was 1.0 (range 0-4.0). PedMS risk was higher in subjects with fathers who were current smokers (crude OR 1.94, 95% CI 1.10-3.40) or who smoked 3 months' pre-pregnancy (crude OR 1.79, 95% CI 1.03-3.11). The risk increased when both parents smoked (crude OR 2.03, 95% CI 1.12-3.68) and was highest when both smoked 3 months before pregnancy (crude OR 10.79, 95% CI 1.30-89.54), even after adjustments. No significant association was found with maternal smoking.

conclusionParental smoking, particularly paternal smoking current habit and before pregnancy, may increase the risk of PedMS. Promoting smoke-free behaviors among parents could therefore represent a feasible preventive approach to limit early-life environmental factors involved in disease susceptibility.

Indexed as

Cigarette smoke exposureEpidemiologyMultiple sclerosisPediatricsRisk factors

Identifiers

PMID41706361
PMCPMC12965922

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.